Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

This study has been terminated.
(Study has been terminated due to slow enrollment.)
Mayo Clinic
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: June 28, 2012
Last updated: March 28, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 28, 2016